COUNTRY OF ORIGIN — AUSTRALIAN

SORT date author clear filters


FILTER RECORDS BY


Leighton Kesteven H (1919)
A study of epidemic influenza in Australia. Lancet 2:1189-91.

View

Macnamara J (1933)
Serum therapy in poliomyelitis. BMJ 1:526-8.

View

Rosenthal DB (1936)
The incidence of pleural effusion in artificial pneumothorax. BMJ 1:95-99.

View

Lancaster HO (1951) (1951)
Quantitative methods in biological and medical sciences. Springer: New York.

View

McBride WG (1961)
Thalidomide and congenital abnormalities. Lancet 2:1358.

View

Andrews G, Guitar B, Howie P (1980)
Meta-analysis of the effects of stuttering treatment. Journal of Speech and Hearing Disorders 45:287-307.

View

Andrews G, MacMahon SW, Austin A, Byrne DG (1982)
Hypertension: comparison of drug and non-drug treatments. BMJ 284:1523-1526.

View

Lloyd DM, Alexander HM, Callcott R, Dobson AJ, Hardes GR, O'Connell DL, Leeder SR (1983)
Cigarette smoking and drug use in schoolchildren: III--evaluation of a smoking prevention education programme Int J Epidemiol 12:51-8.

View

Dwyer T, Coonan WE, Leitch DR, Hetzel BS, Baghurst RA (1983)
An investigation of the effects of daily physical activity on the health of primary school students in South Australia. International Journal of Epidemiology 12:308-13.

View

King JF, Keirse MJNC, Grant A, Chalmers I (1985)
Tocolysis - the case for and against. In: Beard RW, Sharp F, eds. Preterm Labour and its Consequences. London: Royal College of Obstetricians and Gynaecologists, 1985:199-208.

View

Simes RJ (1986)
Publication bias: the case for an international registry of clinical trials. Journal of Clinical Oncology 4:1529-41.

View

King JF, Grant A, Keirse MJNC, Chalmers I (1988)
Betamimetics in preterm labour: an overview of the randomized controlled trials. British Journal of Obstetetrics and Gynaecology 95:211-222.

View

Walker R, Heller R, Redman S, O’Connell D, Boulton J (1992)
Reduction of ischemic heart disease risk markers in the teenage children of heart attack patients. Preventive Medicine 21:616-629.

View

Gomel M, Oldenburg B, Simpson JM, Owen N (1993)
Work-site cardiovascular risk reduction: A randomized trial of health risk assessment, education, counseling, and incentives. American Journal of Public Health 83:1231-1238.

View

Simpson JM, Klar N, Donner A (1995)
Accounting for cluster randomization: a review of primary prevention trials, 1990 through 1993. American Journal of Public Health 85:1378-1383.

View

O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW (2006)
1,026 experimental treatments in acute stroke. Annals of Neurology 59:467-77. https://doi.org/10.1002/ana.20741

View

Kramer MS, Martin RM, Sterne JA, Shapiro S, Mourad D, Platt RW (2009)
The double jeopardy of clustered measurement and cluster randomisation. BMJ 339:503-505.

View

Sena ES, Briscoe CL, Howells DW, Donnan GA, Sandercock PA, Macleod MR (2010)
Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis. Journal of Cerebral Blood Flow and Metabolism 30:1905-13.

View

Begley CG, Ellis LM (2012)
Raise standards for preclinical cancer research. Nature 483:531.

View

Tsilidis KK, Panagiotou OA, Sena ES, Aretouli E, Evangelou E, Howells DW, Salman RA, Macleod MR, Ioannidis JPA (2013)
Evaluation of excess significance bias in animal studies of neurological diseases. PLoS Biol 11: e1001609. doi:10.1371/journal.pbio.1001609.

View

Page MJ, McKenzie JE, Kirkham J, Dwan K, Kramer S, Green S, Forbes A (2014)
Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions. Cochrane Database of Systematic Reviews 2014;(10):MR000035.

View

Sena ES, Currie GL, McCann SK, Macleod MR, Howells DW (2014)
Systematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically. J Cereb Blood Flow Metab 34:737-742. doi:10.1038/jcbfm.2014.28

View

Punja S, Xu D, Schmid CH, Hartling L, Urichuk L, Nikles CJ, Vohra S (2016)
N of 1 trials can be aggregated to generate group mean treatment effects: A systematic review and meta-analysis. Journal of Clinical Epidemiology 76:65-75.

View

Page MJ, Higgins JPT, Clayton G, Sterne JAC, Hróbjartsson A, Savović J (2016)
Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies. PLOS ONE 11(7):e0159267.

View

Imberger G, Thorlund K, Gluud C, Wetterslev J (2016)
False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review. BMJ Open 6(8):e011890.

View

Chalmers I, Atkinson P, Badenoch D, Glasziou P, Austvoll-Dahlgren A, Oxman A, Clarke M (2019)
The James Lind Initiative: books, websites and databases to promote critical thinking about treatment claims, 2003 to 2018. Research Involvement and Engagement 5:6. https://doi.org/10.1186/s40900-019-0138-2

View

Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, Garner P, Holgate ST, Howells DW, Karp NA, Lazic SE, Lidster K, MacCallum CJ, Macleod M, Pearl EJ, Petersen OH, Rawle F, Reynolds P, Rooney K, Sena ES, Silberberg SD, Steckler T, Würbel H (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol 18(7): e3000410. https://doi.org/10.1371/journal.

View

Laursen DRT, Nejstgaard CH, Bjørkedal E, Frost AD, Hansen MR, Paludan-Müller AS, Prosenz J, Werner CP, Hróbjartsson A. (2023)
Impact of active placebo controls on estimated drug effects in randomised trials: a systematic review of trials with both active placebo and standard placebo. Cochrane Database of Systematic Reviews 3(3):MR000055.

View

Glasziou P, Jones M, Clarke M (2024)
Setting new research in the context of previous research: some options. BMJ Evidence Based Medicine. 29(1):44-46

View

Nothing found, please try resetting your search filters